AirSculpt Technologies (NASDAQ:AIRS) Major Shareholder Jorey Chernett Purchases 90,000 Shares

AirSculpt Technologies, Inc. (NASDAQ:AIRS) major shareholder Jorey Chernett acquired 90,000 shares of the firm’s stock in a transaction that occurred on Friday, April 3rd. The shares were purchased at an average price of $2.82 per share, with a total value of $253,800.00. Following the completion of the acquisition, the insider owned 6,933,761 shares of the company’s stock, valued at $19,553,206.02. This represents a 1.32% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Major shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.

Jorey Chernett also recently made the following trade(s):

• On Monday, March 23rd, Jorey Chernett bought 50,000 shares of AirSculpt Technologies stock. The stock was purchased at an average price of $2.91 per share, for a total transaction of $145,500.00.
• On Friday, March 20th, Jorey Chernett purchased 40,000 shares of AirSculpt Technologies stock. The shares were acquired at an average cost of $2.77 per share, with a total value of $110,800.00.
• On Thursday, March 19th, Jorey Chernett acquired 77,702 shares of AirSculpt Technologies stock. The stock was acquired at an average price of $2.64 per share, for a total transaction of $205,133.28.
• On Tuesday, March 17th, Jorey Chernett acquired 83,000 shares of AirSculpt Technologies stock. The stock was acquired at an average cost of $2.56 per share, for a total transaction of $212,480.00.
• On Monday, March 16th, Jorey Chernett bought 105,848 shares of AirSculpt Technologies stock. The shares were acquired at an average price of $2.43 per share, with a total value of $257,210.64.
• On Wednesday, March 11th, Jorey Chernett bought 88,000 shares of AirSculpt Technologies stock. The stock was acquired at an average cost of $2.15 per share, with a total value of $189,200.00.
• On Friday, March 6th, Jorey Chernett purchased 45,600 shares of AirSculpt Technologies stock. The shares were acquired at an average cost of $2.00 per share, for a total transaction of $91,200.00.
• On Wednesday, March 4th, Jorey Chernett acquired 30,000 shares of AirSculpt Technologies stock. The shares were acquired at an average price of $1.87 per share, with a total value of $56,100.00.
• On Tuesday, March 3rd, Jorey Chernett acquired 80,000 shares of AirSculpt Technologies stock. The stock was bought at an average price of $1.71 per share, with a total value of $136,800.00.

AirSculpt Technologies Stock Down 1.4%

Shares of NASDAQ:AIRS traded down $0.04 during midday trading on Monday, reaching $3.13. The company had a trading volume of 683,372 shares, compared to its average volume of 2,702,874. The company has a quick ratio of 0.51, a current ratio of 0.51 and a debt-to-equity ratio of 0.63. The business’s 50 day moving average price is $2.34 and its 200 day moving average price is $4.34. The stock has a market cap of $220.54 million, a PE ratio of -16.40 and a beta of 2.22. AirSculpt Technologies, Inc. has a 1-year low of $1.51 and a 1-year high of $12.00.

AirSculpt Technologies (NASDAQ:AIRS) last issued its quarterly earnings results on Tuesday, March 31st. The company reported $0.02 EPS for the quarter, beating the consensus estimate of ($0.03) by $0.05. The firm had revenue of $33.44 million during the quarter, compared to analysts’ expectations of $34.93 million. AirSculpt Technologies had a negative return on equity of 14.30% and a negative net margin of 11.41%.The business’s quarterly revenue was down 14.8% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.09) earnings per share. Research analysts forecast that AirSculpt Technologies, Inc. will post -0.01 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on AIRS. Weiss Ratings reiterated a “sell (d-)” rating on shares of AirSculpt Technologies in a report on Monday, December 29th. Wall Street Zen raised shares of AirSculpt Technologies from a “sell” rating to a “hold” rating in a research report on Sunday. One equities research analyst has rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Reduce” and a consensus price target of $6.00.

Hedge Funds Weigh In On AirSculpt Technologies

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Balyasny Asset Management L.P. grew its holdings in shares of AirSculpt Technologies by 128.5% during the 2nd quarter. Balyasny Asset Management L.P. now owns 1,113,843 shares of the company’s stock worth $5,380,000 after purchasing an additional 626,309 shares in the last quarter. Renaissance Technologies LLC bought a new stake in AirSculpt Technologies during the fourth quarter worth about $1,991,000. Vanguard Group Inc. grew its stake in AirSculpt Technologies by 10.8% during the third quarter. Vanguard Group Inc. now owns 782,543 shares of the company’s stock worth $6,276,000 after buying an additional 76,291 shares in the last quarter. Geode Capital Management LLC increased its holdings in AirSculpt Technologies by 4.6% in the 4th quarter. Geode Capital Management LLC now owns 403,163 shares of the company’s stock valued at $798,000 after buying an additional 17,889 shares during the period. Finally, FourWorld Capital Management LLC increased its holdings in AirSculpt Technologies by 50.0% in the 2nd quarter. FourWorld Capital Management LLC now owns 382,886 shares of the company’s stock valued at $1,849,000 after buying an additional 127,676 shares during the period. 91.54% of the stock is owned by institutional investors and hedge funds.

AirSculpt Technologies Company Profile

AirSculpt Technologies, Inc (NASDAQ: AIRS) is a medical technology company specializing in minimally invasive body contouring. The company’s flagship AirSculpt® platform combines pneumatic power with precision microcannulas to deliver fat removal, transfer and sculpting procedures. AirSculpt Technologies partners with both company-owned and franchised cosmetic surgery practices to offer a streamlined, office-based alternative to traditional liposuction.

Through its proprietary system, AirSculpt Technologies provides both consumers and medical professionals with an integrated solution that emphasizes reduced downtime, smaller incision sites, and more predictable outcomes.